Smart Pill Market is projected to grow at a CAGR of 12.43% during the forecast period, reaching a total market size of US$4.856 billion in 2024 from US$2.405 billion in 2018. Rising prevalence of gastrointestinal diseases such as colon cancer is boosting the demand for smart pill technology on account of minimally invasive surgeries. Growing demand for minimally invasive surgeries and replacement of painful injections with painless pills is spurring the growth of smart pill market. Technologic Read more...
Smart Healthcare Devices market is projected to grow at a CAGR of 16.14% during the forecast period, reaching a total market size of US$232.642 billion in 2024 from US$94.790 billion in 2018. Smart Healthcare means the use of electronics and other internet of things (IoT) for better diagnosis of diseases, improved treatment of patients, and enhanced quality of life. It helps in giving real-time health-related information of patients and thereby supporting chronic disease management and remote Read more...
The North America antibody-drug conjugates (ADCs) market is expected to reach a market size of $5,619.220 million by 2024 with a CAGR of 27.33%. The market is propelled to grow during the forecast period owing to the extensive research which is being carried out by the big companies situated in this region to find an effective cure for several malignancies, haematological and non-haematological. The growing health expenditure is further contributing to the market growth in the forecast period Read more...
The Asia Pacific antibody-drug conjugates (ADCs) market is expected to grow at a CAGR of 27.64% to reach a market size of USD2,271.411 million by the end of 2024. Antibody-drug conjugates are the novel and emerging class of anti-cancer therapies consisting of empowered monoclonal antibodies (mAbs) designed to harness the targeting ability of monoclonal antibodies by linking them to cell-killing agents. They consist of covalently linked monoclonal antibodies to small molecule drugs that target Read more...
The Europe antibody-drug conjugates (ADCs) market is expected to grow at a CAGR of 23.87% to reach a market size of USD2,421.585 million by the end of 2024. The market for antibody-drug conjugates is poised to grow at a rapid pace in the European region with the growing innovations in biotechnology leading to the formation of highly potent pharmaceutical drugs in the forecast period and in the coming years. Also, several companies based in this region are working on the development of highly p Read more...
The USA antibody-drug conjugates (ADCs) market is expected to grow with a CAGR of 27.51 percent to achieve a market size of USD5,318.400 million by the end of 2024. The antibody-drug conjugate technology provides a promising and effective strategy for targeted cancer treatment, hence promoting market growth during the forecast period in the United States. The Seattle Genetics, which is a biotechnology company headquartered in Bothell, Washington has an antibody-drug conjugate drug named as ADC Read more...
Neurosurgical Robotics market is projected to grow at a CAGR of 14.22% during the forecast period, reaching a total market size of US$136.764 million in 2024 from US$61.596 million in 2018. Robotic neurosurgery offers high precision access to the complex and sensitive regions and thereby assisting in microsurgery and minimally invasive surgery. Increasing number of neurosurgeries performed globally and rising geriatric population are boosting the growth of neurosurgical robotics market. Increa Read more...
Medical Cloud market is projected to grow at a CAGR of 22.23% during the forecast period, reaching a total market size of US$47.268 billion in 2024 from US$14.175 billion in 2018. Medical and health care sector is witnessing continuous technological advancements. Cloud computing systems have made the healthcare sector more cost-efficient and convenient. Rise in the adoption of information technology in the health care sector has boosted the growth of the market. Stringent regulations, in Read more...
Genome Editing market is projected to grow at a CAGR of 12.39% during the forecast period, reaching a total market size of US$6.385 billion in 2024 from US$3.168 billion in 2018. Genome editing or gene editing is a group of technologies that give scientists the ability to change an organism's DNA by adding, removing, or altering genetics. Rising government funding and increasing genomics projects are boosting the growth of the market. The growing prevalence of cancer and other diseases and techn Read more...
The Tissue Banking market is projected to grow at a CAGR of 2.69% during the forecast period, reaching a total market size of US$2.774 billion in 2024 from US$2.366 billion in 2018. Tissue banks facilitate the collection and banking of freshly-frozen tissue specimens. The market of tissue banking is boosting on account of tremendous advancement in medical research, clinical trials, and biopharmaceutical industries. Increasing investment in the medical and healthcare sector and advances in Read more...
.jpg)
